Novel Competition Combines Crowdsourcing and Data Sharing to Drive Innovation in Prostate Cancer Research

Industry leaders in biomedical research, oncology data sharing and computational science recently announced the launch of an innovative research challenge for prostate cancer using previously unavailable clinical data. The Prostate Cancer DREAM Challenge is the first research challenge in prostate cancer to marry crowdsourcing with data sharing, paving a new way to tackle key research questions about metastatic castration-resistant prostate cancer (mCRPC), an advanced form of the disease with poor outcomes. Sign up to participate in the Challenge at:!Synapse:syn2813558.

SCIEX Announces OneOmics Collaborators

SCIEX, a global leader in life science analytical technologies, recently announced collaborators in the OneOmics™ project, an exclusive partnership between Illumina and SCIEX that integrates SWATH™ Acquisition based next-generation proteomics (NGP) and next-generation sequencing (NGS) data on the BaseSpace® cloud computing environment. Advaita Bioinformatics, The Institute for Systems Biology (ISB) and researchers at Yale University have each developed cloud-based applications and libraries that utilize SWATH Proteomics data in novel ways allowing researchers to analyze and compare proteomics and genomics data. This effort furthers the OneOmics project’s goal of eliminating the informatics barriers that exist between different Omics disciplines.

10X Genomics Launches GemCode Platform, Provides Long Range Information with Short Read Sequencing

10X Genomics recently launched the GemCode™ Platform at the 16th annual Advances in Genome Biology and Technology (AGBT). The GemCode Platform is a unique molecular barcoding and analysis platform that consists of instrumentation, reagents and software, which delivers long range information, including haplotype phasing, structural variation and de novo assembly. By upgrading existing short read sequencers the GemCode Platform generates a powerful new data type: linked reads.

LabCorp Presents New Findings on HIV-1 and HCV Antiviral Drug Resistance at the 2015 Conference on Retroviruses and Opportunistic Infections


Laboratory Corporation of America® Holdings (LabCorp®) (NYSE: LH) announced today that Monogram Biosciences, Inc., a member of the LabCorp Specialty Testing Group, presented two new studies characterizing HIV-1 and HCV antiviral drug resistance at the 2015 Conference on Retroviruses and Opportunistic Infections (CROI 2015). The conference was held at the Washington State Convention Center, in Seattle, Washington. Monogram’s studies were presented on February 25th and 26th, 2015.

Biodesix And Inivata To Investigate Clinical Utility Of Next Generation Sequencing-Blood Based Tests For Patients With Advanced Lung Cancer

Biodesix, Inc., a Boulder CO-based molecular diagnostics company, and Inivata, a Cambridge, England-based clinical cancer genomics company announced a partnership today to develop and commercialize Next Generation Sequencing (NGS)-blood based tests for clinical applications in lung cancer. This agreement will leverage Inivata’s proprietary, enhanced TAm-Seq™ technology platform and Biodesix’ development and commercialization capabilities in the US market to provide new, clinically actionable tests to physicians.